The global psoriasis therapeutics market was valued at $22.9 billion in 2021, and is projected to reach $55.8 billion by 2031, growing at a CAGR of 9.3% from 2022 to 2031.
Report Code : A03405 | Pages : 242 | Category : Life Sciences
The global pneumonia vaccines market was valued at $7,083 million in 2017 and is expected to reach $10,215 million by 2025, growing at a CAGR of 5% from 2018 to 2025.
Report Code : A02397 | Pages : 171 | Category : Life Sciences
The global compression therapy market was valued at $3.2 billion in 2021, and is projected to reach $5.4 billion by 2031, growing at a CAGR of 5.4% from 2022 to 2031.
Report Code : A03966 | Pages : 400 | Category : Life Sciences
The global ulcerative colitis market was valued at $6.2 billion in 2020, and is projected to reach $10.8 billion by 2030, growing at a CAGR of 5.7% from 2021 to 2030.
Report Code : A03620 | Pages : 225 | Category : Life Sciences
The global diabetes care devices market was valued at $20.0 billion in 2020, and is projected to reach $38.3 billion by 2030, growing at a CAGR of 6.6% from 2021 to 2030.
Report Code : A02507 | Pages : 180 | Category : Life Sciences
The global pulmonary arterial hypertension treatment market was valued at $7,177.81 million in 2021, and is projected to reach $11,968.60 million by 2031, growing at a CAGR of 5.2% from 2021 to 2031.
Report Code : A05105 | Pages : 335 | Category : Life Sciences
The global cystic fibrosis (cf) therapeutics market was valued at $12.9 billion in 2024, and is projected to reach $32.3 billion by 2034, growing at a CAGR of 9.6% from 2025 to 2034.
Report Code : A05134 | Pages : 254 | Category : Life Sciences
The global spirulina market was valued at $393.6 million in 2019, and is projected to reach $897.61 million by 2027, registering a CAGR of 10.5% from 2020 to 2027.
Report Code : A03875 | Pages : 246 | Category : Life Sciences
The global varicella live vaccine market was valued at $2,714 million in 2018, and is expected to reach $4,222 million by 2026, registering a CAGR of 5.7% from 2019 to 2026.
Report Code : A03624 | Pages : 178 | Category : Life Sciences
The global diabetic retinopathy market size was valued at $3,086.00 million in 2020, and is projected to reach $10,785.50 million by 2030, registering a CAGR of 13.7% from 2021 to 2030.
Report Code : A01680 | Pages : 157 | Category : Life Sciences
